{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:04:10Z","timestamp":1777421050872,"version":"3.51.4"},"reference-count":5,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T00:00:00Z","timestamp":1598659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Ann Pharmacother"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1177\/1060028020953631","type":"journal-article","created":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T06:39:24Z","timestamp":1598683164000},"page":"556-557","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":6,"title":["Successful Bictegravir\/Emtricitabine\/Tenofovir Alafenamide Treatment in a HIV Patient With Swallowing Difficulties"],"prefix":"10.1177","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5245-9353","authenticated-orcid":false,"given":"Javier S\u00e1nchez-Rubio","family":"Ferr\u00e1ndez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angel L\u00f3pez","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel Gaspar","family":"Alonso-Vega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto Onteniente","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa Molina","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2020,8,29]]},"reference":[{"key":"bibr1-1060028020953631","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-012-1417-0"},{"key":"bibr2-1060028020953631","doi-asserted-by":"publisher","DOI":"10.1016\/j.medmal.2019.10.010"},{"key":"bibr3-1060028020953631","unstructured":"Foisy M, Hughes C. Oral antiretroviral\/HCV DAA administration: information on crushing and liquid drug formulations. Accessed June 7, 2020. https:\/\/www.hivclinic.ca\/main\/drugs_extra_files\/Crushing%20and%20Liquid%20ARV%20Formulations.pdf"},{"key":"bibr4-1060028020953631","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104717"},{"key":"bibr5-1060028020953631","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/zxaa017"}],"container-title":["Annals of Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1060028020953631","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1060028020953631","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1060028020953631","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:15:51Z","timestamp":1777374951000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1060028020953631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,29]]},"references-count":5,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["10.1177\/1060028020953631"],"URL":"https:\/\/doi.org\/10.1177\/1060028020953631","relation":{},"ISSN":["1060-0280","1542-6270"],"issn-type":[{"value":"1060-0280","type":"print"},{"value":"1542-6270","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,29]]}}}